These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 214607)

  • 21. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multiplication, interference, and interferon induction of avian herpesviruses. Contribution to the vaccination against Marek's disease. 2. Materials and methods, results, discussion and conclusion].
    Kaleta EF
    Zentralbl Veterinarmed B; 1977 Jun; 24(6):429-75. PubMed ID: 196461
    [No Abstract]   [Full Text] [Related]  

  • 23. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced shedding of Marek's disease virus from feather follicles of bivalent vaccinated chickens.
    Pruthi AK; Gupta RK; Sadana JR
    Indian J Exp Biol; 1987 Jun; 25(6):405-7. PubMed ID: 2831141
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative 50% protective dose assays (PD50) of Marek's disease virus strain CVI988.
    De Boer GF; Orthel FW; Krasselt M; Oei HL; Pereboom WJ; Barendregt LG
    J Biol Stand; 1981 Jan; 9(1):15-22. PubMed ID: 6260810
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of herpesviruses in Marek's disease lymphoma of chickens.
    Nazerian K; Lee LF; Sharma JM
    Prog Med Virol; 1976; 22():123-51. PubMed ID: 185662
    [No Abstract]   [Full Text] [Related]  

  • 30. Marek's disease vaccines.
    Calnek BW
    Dev Biol Stand; 1982; 52():401-5. PubMed ID: 6299850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marek's disease virus.
    Kato S; Hirai K
    Adv Virus Res; 1985; 30():225-77. PubMed ID: 3008524
    [No Abstract]   [Full Text] [Related]  

  • 32. Marek's disease vaccine: prophylactic efficacy of a lyophilized turkey herpesvirus of chick cell-culture origin.
    Kilgore RL; Brokken ES
    Avian Dis; 1973; 17(1):137-41. PubMed ID: 4633273
    [No Abstract]   [Full Text] [Related]  

  • 33. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA; Williams DL; Reilly JD
    Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunogenic activity of vaccines against Marek's disease].
    Persov AS; Korovin RN; Lokh VA; Aĭrapetov RG; Matiushkov VS
    Veterinariia; 1978 Jul; (7):41-2. PubMed ID: 210559
    [No Abstract]   [Full Text] [Related]  

  • 39. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation the immuno-protective effect of an infectious clone of meq- deleted Marek's disease virus].
    Li Y; Kang M; Su S; Ding J; Cui Z; Zhu H
    Wei Sheng Wu Xue Bao; 2010 Jul; 50(7):942-8. PubMed ID: 20815243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.